Company: APM
Filing Date: 2025-07-15
Form Type: DRS
Source: 0001213900-25-063899
Chunk: 319

Company: Aptorum Group Ltd
Filing Date: 2025-07-15
Form: DRS
Chunk 319
---
) at Wayne State University School of Medicine, Detroit MI. He received his post-doc training
in Molecular Biology and Genetics from Prof. David C. Ward at Yale University, and Ph.D. in Chemistry from Lucknow University, India.

Kenny K. Ablordeppey, MS, Laboratory Supervisor & Project Manager. Mr. Ablordeppey joined DiamiR in April 2021. Prior to joining DiamiR, he was
the Project Manager for Assay Development at Interpace Biosciences. From 2017 to 2021, he managed the completion of product development,
validation, and launch of molecular diagnostic tests for thyroid malignancy. He has a M.S in Molecular and Cellular Biology and a B.S
in Biochemistry and Molecular Biology from the University of Massachusetts, Amherst.

Scientific Advisory Board

The Scientific Advisory Board
shall help the Company sharpen its focus on innovation and technological advancements and address critical scientific challenges in its
research and development; it will provide overall advice on the scientific development of the company. As of the date of this prospectus,
Diamir has 4 members on this board.

Henry (Harv) M. Rinder, MD, MA, FACP, FASCP, Professor of Laboratory Medicine & Internal Medicine (Hematology), Yale School of Medicine & Yale-New Haven Hospital.
He received a BS degree from Yale and MD from UVM, where he also completed a post-sophomore pathology fellowship under John Craighead,
Jack Clemmons, and Wash Winn. Harv trained in internal medicine and was chief medical resident at Maine Medical Center with Bob Hillman
and Ken Ault, then returned to Yale School of Medicine for training in hematology and clinical pathology under the tutelage of Bernie
Forget, Ed Benz, Brian Smith, and Peter Jatlow, coming on staff at Yale New Haven Hospital in 1992. Dr. Rinder is active in research on
molecular mechanisms of inflammation, platelets, and hemostasis; he consults in hematology, teaches residents and fellows in pathology
and hematology, and directs the hematology laboratory at Yale-New Haven Hospital. Harv is an active collaborator on multiple clinical
and translational research, as well as industry/pharma, projects. Dr. Rinder is a volunteer for the ASCP, serving on committees tasked
with education and professional development, and currently is President of the ASCP, serving the pathology and laboratory professional
workforce.